seed
Stage
2022
Founded
1
Investors
About
Navignostics is a precision diagnostics company developing spatial proteomics technology to analyze tumor tissue at single-cell resolution. This provides comprehensive molecular profiles to guide personalized cancer treatment decisions for patients.
Explore Navignostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.